Search Results
Results found for "Structure Therapeutics"
- Vaithish Velazhahan | Dr. GPCR Ecosystem
His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs developed novel tools and methodologies to study fungal GPCRs which allowed the determination of the first structures
- Student Flash Presentations | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Presentations Health and Disease, Metabolism, Nervous System, Proteomics and Transcriptomics, Receptor Structure The shorter BAI1 isoforms lack most of the N-terminus and are very close in structure to the truncated graduate student, he worked in the EuGEF Research Group to identify novel prognostic biomarkers and therapeutic significant tissue-specific mRNA processing that results in holoreceptors with unique and variable N-terminal structures Clearly, a new, less toxic therapeutic is needed.
- Dr. Demet Araç | Dr. GPCR Ecosystem
Axel Brunger’s lab at Stanford University to study the structure and function of cell-adhesion proteins journey of studying adhesion GPCRs, the challenges he faced, and the progress made in understanding their structure adhesion GPCRs, outlining his collaborations, challenges, and the progress made in understanding their structure collaborations and improved their understanding of the GPCRs through various approaches, including structural the field has seen significant growth, with important discoveries such as the transmembrane region structures
- Dr. Marta Filizola | Dr. GPCR Ecosystem
The overall goal of her research program is to obtain rigorous mechanistic insights into the structure To this end, her lab uses several computational structural biology tools and rational drug design approaches
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics
- Dr. Stuart Maudsley | Dr. GPCR Ecosystem
At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based therapeutics
- Session III | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
technology for high-throughput screening of pharmacological compound libraries to identify potential therapeutic "Ana Lilia Moreno Salinas (2), Arturo Mancini (1), Raida Jallouli (2), Richard Leduc (2) (1)Domain Therapeutics Laurent Sabbagh on the web Domain Therapeutics Characterizing hADGRE5/CD97 Activation and Signaling: Domain Therapeutics North America Inc., Montreal, Quebec, Canada 3.
- Dr. Yamina Berchiche | Dr. GPCR Ecosystem
The explosion of biomedical data such as in genomics, structural biology, and pharmacology can provide How can we best leverage these exciting new techniques in areas such as protein structure prediction,
- GPCR Pharmacology, Career Twists & Serendipity with Sokhom Pin | Dr. GPCR Ecosystem
From his early work as a technician at Johns Hopkins Hospital to leading biology at Servo Therapeutics years of drug discovery research in the pharmaceutical industry, where he works mainly on GPCRs as therapeutic He is passionate about mechanistic profiling of therapeutic molecules as well as drug discovery in general
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
Yamina underscores the therapeutic potential of GPR65, especially in the context of cancer immunotherapy , and how understanding receptor activity in acidic micro environments could unlock new therapeutic strategies
- Dr. Lauren M. Slosky | Dr. GPCR Ecosystem
protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics
- Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma
of GPCRs in disease states to help test the feasibility of using protein-targeted degradation as a therapeutic
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
Keyvan Sedaghat discussing how GPCR function is shaped by lipid raft compartmentalization, the expanding therapeutic efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel therapeutic
- YC-BioTech | Dr. GPCR Ecosystem
guides program momentum Focus resources where they’ll change outcomes No More Strategy Swirl I build structure up clear deliverables across internal and CRO teams Keep cross-functional teams moving with shared structure
- Celtarys Research | Dr. GPCR Ecosystem
Biology: The Role of Fluorescent Ligands in GPCR Research GPCRs are one of the most important families of therapeutic Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic
- Tanishka S. Saraf | Dr. GPCR Ecosystem
Saraf " My research focuses on evaluating and targeting serotonin 1A receptors for therapeutic outcomes
- Dr. Terry Hébert | Dr. GPCR Ecosystem
Terry Hébert is a Professor within the Department of Pharmacology & Therapeutics at McGill University
- Univeristy Lecturers Details | Dr. GPCR Ecosystem
. 🧭 Full-Length Course Structure: 4 × 1-hour sessions Purpose: Deep, multi-session learning experience Best for: Comprehensive topics that require exploration and discussion ⚡ Short Course Structure: 1 session coverage of key concepts Best for: Core methods, applied principles, or emerging topics 🔍 Mini Course Structure instructor agreement (you’ll receive the full version right after submission). 🧱 Step 2: Plan Your Course Structure
- Dr. Jean-Philippe Pin | Dr. GPCR Ecosystem
biosensors, cryo-EM, photoswitchable ligands, and nanobodies as pharmacological tools and potential therapeutic
- Hacking GPCRs: Tools, Tech & Drug Discovery with Tom Sakmar & Ilana Kotliar | Dr. GPCR Ecosystem
This could accelerate discovery of therapeutic targets by combining multiplex data with focused downstream As the field advances, the computational layer — including AlphaFold and structural prediction tools
- Illuminating Functional Selectivity and Allosterism at GPCRs.
He is also an Associate Leader of the Experimental Therapeutics and Metabolism Program and the Director
- Timeline Strategy | Scaling Biotech Operations with Dr. GPCR
objectives ✅ Build internal systems and workflows that support scale ✅ Create investor-ready operating structures It is the nature of scientific possibility. 👉 The problem begins when ambition grows faster than structure
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
Membrane Proteins and Receptors (COMPARE), University of Nottingham, where he provides leadership in structural group leader at the Paul Scherrer Institute and ETH Zürich in Switzerland, changing his attention to structural
- Trainee Symposium II
My primary research focus lies in gaining deeper insights into the structural mechanisms governing G lab for her postdoc in 2018 where she has employed protein engineering, receptor pharmacology, and structural
- Targeting adenosine signaling for immuno-oncology
clinical stage company developing next generation immunotherapies, and member of the SAB of Domain Therapeutics
- GPCR CRO Bank | Dr. GPCR Ecosystem
The CRO Bank allows companies to present their services and platforms in a structured format so GPCR ecosystem Support inbound inquiries from teams actively evaluating CROs, platforms, or tools Present clear, structured
- Finance is Science too: How Numbers Keep the Lights On with Chuck DeWeese & Joe St. Germain | Dr. GPCR Ecosystem
Chuck stepped in to help structure the nonprofit’s financial framework , showcasing how specialized knowledge It's about structure, order, and breakthrough moments , not unlike the life of a researcher. help you set up and come back when you’re ready.’” – Chuck DeWeese Accounting for Grants: Buckets, Structure
- Dr. Amynah Pradhan | Dr. GPCR Ecosystem
Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic
- The Role of Quantitative Sciences in GPCRs with Dr. Nagarajan Vaidehi | Dr. GPCR Ecosystem
She has advanced the use of computational methods to meet the challenges of designing therapeutics with

























